Evidence map›Paper›PMID 25000337›Full record

ArticleChemical communications (Cambridge, England)2014

A modular tyrosine kinase deoxyribozyme with discrete aptamer and catalyst domains.

Victor Dokukin, Scott K Silverman

Open access · hybridAbstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Pursuing DNA catalysts for protein modification.Accounts of chemical research · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Victor DokukinDepartment of Chemistry, University of Illinois at Urbana-Champaign, 600 South Mathews Avenue, Urbana, IL 61801, USA. scott@scs.illinois.edu.
Scott K Silverman
University of Illinois Urbana-Champaign · USUrbana University · US

Funding

Training Program in Chemistry-Interface with BiologyT32GM070421 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI HERGENROTHER, PAUL · 2005 to 2019
$5.4M
Deoxyribozymes that ligate RNAR01GM065966 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI SILVERMAN, SCOTT K · 2003 to 2016
$4.2M
4800 Plus MALDI TOF/TOF AnalyzerS10RR027109 · NCRR · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI VAN DER DONK, WILFRED A. · 2010 to 2010
$395k
HIGH-SENSITIVITY PROTEIN SEQUENCING FACILITYS10RR002710 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI TANG, JORDAN J · 1986 to 1986
–
NCRR NIH HHS S10 RR027109NCRR NIH HHS S10RR027109ANIGMS NIH HHS R01 GM065966NIGMS NIH HHS R01GM065966NIGMS NIH HHS T32 GM070421NIGMS NIH HHS T32GM070421
6 · The paper itself

Abstract

We assess the utility of integrating a predetermined aptamer DNA module adjacent to a random catalytic DNA region for identifying new deoxyribozymes by in vitro selection. By placing a known ATP aptamer next to an N40 random region, an explicitly modular DNA catalyst for tyrosine side chain phosphorylation is identified. The results have implications for broader identification of deoxyribozymes that function with small-molecule substrates.

Indexed as

Aptamers, NucleotideBase SequenceCatalytic DomainDNA, CatalyticMolecular Sequence DataProtein-Tyrosine KinasesAptamers, NucleotideDNA, CatalyticProtein-Tyrosine Kinases

Identifiers

PMID25000337
PMCPMC4126072
OpenAlexW1998996962

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.